Biohaven

Company Deals

Biohaven Acquires Global Rights for Dual TYK2/JAK1 Inhibitor BHV-8000 from Highlightll

Fineline Cube Mar 23, 2023

US-based Biohaven Ltd. (NYSE: BHVN) has announced the acquisition of global rights, excluding China regions,...

Company Deals

Sanofi Completes Vicebio $1.6B Acquisition, Adds RSV Vaccine Platform

Company Drug

Juventas CAR-T LBCL Launch Marks Second Indication

Company Drug

BMS Breyanzi MZL FDA Approval First CAR-T

Company Deals

Formosa Pharma APP13007 Clobetasol ASEAN Deal with Rxilient